Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Hypertension Inc. Stories

2013-12-18 13:41:25

Presented by the American Society of Hypertension Inc. and the International Society of Hypertension High blood pressure affects approximately one in three adults in the Americas, Europe, some Asian countries and Australia, and one billion people worldwide. Because of this epidemic, The American Society of Hypertension, Inc. (ASH) and the International Society of Hypertension (ISH) are pleased to announce the creation of first-of-their-kind guidelines for the diagnosis and treatment of...

2013-12-17 20:20:40

Presented by the American Society of Hypertension, Inc. and the International Society of Hypertension NEW YORK, Dec. 17, 2013 /PRNewswire/ -- High blood pressure affects approximately one in three adults in the Americas, Europe, some Asian countries and Australia, and one billion people worldwide. Because of this epidemic, The American Society of Hypertension, Inc. (ASH) and the International Society of Hypertension (ISH) are pleased to announce the creation of first-of-their-kind...

2013-06-20 20:22:06

NEW YORK, June 20, 2013 /PRNewswire/ -- A recent shift in the National Heart, Lung and Blood Institute (NHLBI) health education agenda has prompted hypertension-related organizations to spearhead the development and implementation of national hypertension practice guidelines. As published in CIRCULATION today, the NHLBI announced it will no longer develop national clinical practice guidelines, like the highly anticipated Joint National Committee Reports on the Prevention, Detection, and...

2013-04-22 12:31:15

NEW YORK, April 22, 2013 /PRNewswire/ -- The American Society of Hypertension, Inc. (ASH) strongly endorses the current efforts of the World Health Organization (WHO)--the United Nations health agency--to bring attention to the prevention and control of hypertension, a global epidemic that affects approximately one billion people worldwide, including one in three adults in the United States. "Hypertension is one of the most important contributors to stroke and heart disease, which together...

2012-09-12 10:24:33

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- A recently published editorial in the Journal of the American Society of Hypertension (JASH), Ambulatory Blood Pressure Monitoring Should Be Included in the National Health and Nutritional Examination Survey (NHANES)- Vol 6, No 5, 2012, recognizes the importance of this national survey instrument but questions the efficiency of its diagnostic methods in assessing hypertension in the population*. Since the 1960's, CDC has utilized traditional blood...

2012-05-21 10:23:28

EVANSTON, Ill., May 21, 2012 /PRNewswire/ -- After years of reducing their contact with pharmaceutical sales representatives, physicians now risk an unintended consequence: Doctors who rarely meet with pharmaceutical sales representatives -- or who do not meet with them -- are much slower to drop medicines with the Food and Drug Administration's "black box" warnings and to adopt first-in-class therapies. According to a study published today in The Journal of Clinical Hypertension, doctors...

2012-05-18 02:24:23

NEW YORK, May 18, 2012 /PRNewswire/ -- The American Society of Hypertension (ASH) opens its 27th Annual Scientific Meeting on Saturday, May 19, 2012 at the Hilton in New York City. This three and a half day meeting--a scientific forum for clinical investigators and healthcare professionals treating hypertension to present research findings and advances in treatment--will address emerging trends in research and new developments in the approach to treating patients with hypertension and its...

2012-02-02 09:25:00

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- The American Society of Hypertension (ASH) will once again offer the Clinical Hypertension Review Course to cardiologists, nephrologists and internists with an interest in the treatment and management of hypertension. The course will be offered on March 2(nd) and 3(rd), 2012 in Atlanta, GA. The intensive two-day course is designed to be an immersion in evidence-based treatment strategies. It will help current ASH Hypertension specialists...

2011-11-29 02:00:00

ERLANGEN, Germany and BIRMINGHAM, Ala., Nov. 29, 2011 /PRNewswire/ -- Despite ongoing medical care, an alarming 65 percent of people with 'treatment-resistant' hypertension reported in a new survey that high blood pressure remains their most serious health concern, and 79 percent of the respondents said they need new treatment options to get their dangerously high blood pressure under control. To view the multimedia assets associated with this release, please click:...

2011-05-23 09:00:00

DEERFIELD, Ill., May 23, 2011 /PRNewswire/ -- Takeda Global Research & Development Center, Inc. U.S., (TGRD U.S.) today announced results from three phase 3 studies of the investigational fixed-dose combination of azilsartan medoxomil plus chlorthalidone (CLD). In two phase 3 studies, azilsartan medoxomil combined in a fixed-dose with CLD lowered clinic systolic blood pressure (SBP) significantly more than the fixed-dose combination of olmesartan medoxomil plus hydrochlorothiazide...